- জেনেরিক নাম
- Glimepiride + Metformin
- শক্তি
- 1 mg+500 mg
- ডোজ ফর্ম
- Tablet (Extended Release)
- প্রস্তুতকারক
- Synovia Pharma PLC.
- থেরাপিউটিক ক্লাস
- Combination Oral hypoglycemic preparations
৳ ১১.৭৬ ৳ ১২.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Amaryl M 1 mg+500 mg Tablet (Extended Release) একটি Tablet (Extended Release) ঔষধ, যার জেনেরিক নাম Glimepiride + Metformin এবং শক্তি ১ mg+৫০০ mg। Amaryl M প্রস্তুত করেছে Synovia pharma plc। Amaryl M-এর সাথে Glimepiride + Metformin-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। দাম: প্রতি ইউনিট ১২.০০ টাকা। ঔষধটি Combination Oral hypoglycemic preparations শ্রেণির অন্তর্ভুক্ত। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Glimepiride + Metformin-এর ২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Amaryl M এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
Amaryl M is a tablet (extended release) from Synovia Pharma PLC., with the generic name Glimepiride + Metformin. Replacement of combination therapy of glimepiride and metformin. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. Whether it suits you is a decision for your doctor.
Replacement of combination therapy of glimepiride and metformin. Ask your doctor whether it is right for your condition.
Swallow the tablet (extended release) with water. Amaryl M is taken by mouth. Take Amaryl M tablet (extended release) exactly as your doctor prescribes. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the dose or stop early without asking your doctor.
In isolated cases, there may be hepatitis, elevation of liver enzyme levels and/or cholestasis and jaundice, which may progress to life-threatening liver failure. The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke. The cause is a temporary alteration in the turgidity and hence the refractive index of the lens, this being dependent on blood glucose level. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Otherwise, there is risk of harm to the child. Patients must, therefore, remain under close observation. For Glimepiride : In the initial weeks of treatment, the risk of hypoglycemia may be increased and necessitates especially careful monitoring. Keep out of reach of children.
Replacement of combination therapy of glimepiride and metformin. Ask your doctor whether it is right for your condition.
Swallow the tablet (extended release) with water. Amaryl M is taken by mouth.
In isolated cases, there may be hepatitis, elevation of liver enzyme levels and/or cholestasis and jaundice, which may progress to life-threatening liver failure. The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.
The listed price is ৳ ১২.০০.
৳ ১১.৭৬ ৳ ১২.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
This tablet is indicated as an adjunct to diet and exercise in type 2 diabetes mellitus patients-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For Glimepiride:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For Glimepiride-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For Glimepiride:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy-এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For Glimepiride: In the initial weeks of treatment, the risk of hypoglycemia may be increased and necessitates especially careful monitoring. If risk factors for hypoglycemia are present, it may be necessary to adjust the dosage of glimepiride or the entire therapy. This also applies whenever illness occurs during therapy or the patient's life-style changes. It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur. Patients must, therefore, remain under close observation. Severe hypoglycaemia further requires immediate treatment and follow-up by a physician and, in some circumstances, in-patient hospital care. Treatment of patients with G6PD-defciency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-defciency and a non-sulfonylurea alternative should be considered.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For Glimepiride: Acute overdosage, as well as long-term treatment with too high a dose of glimepiride, may lead to severe life-threatening hypoglycaemia. As soon as an overdose of glimepiride has been discovered, a physician must be notifed without delay. The patient must immediately take sugar, if possible in the form of glucose unless a physician has already undertaken responsibility for treating the overdose. Careful monitoring is essential until the physician is confdent that the patient is out of danger. It must be remembered that hypoglycaemia may recur after initial recovery. Admission to hospital may sometimes be necessary even as a precautionary measure. In particular, signifcant overdoses and severe reactions with signs such as loss of consciousness or other serious neurological disorders are medical emergencies and require immediate treatment and admission to hospital. If, for example, the patient is unconscious, an intravenous injection of concentrated glucose solution is indicated (for adults starting with 40 ml of 20% solution, for example). Alternatively in adults, administration of glucagon, e.g. in doses of 0.5 to 1 mg i.v., s.c. or i.m., may be considered. In particular when treating hypoglycaemia due to accidental intake of glimepiride in infants and young children, the dose of glucose given must be very carefully adjusted in view of the possibility of producing dangerous hyperglycaemia, and must be controlled by close monitoring of blood glucose. Patients who have ingested life-threatening amounts of glimepiride require detoxifcation (e.g. by gastric lavage and medicinal charcoal). After acute glucose replacement has been completed it is usually necessary to give an intravenous glucose infusion in lower concentration so as to ensure that the hypoglycaemia does not recur. The patient's blood glucose level should be carefully monitored for at least 24 hours. In severe cases with a protracted course, hypoglycaemia, or the danger of slipping back into hypoglycaemia, may persist for several days.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (not exceeding 25°C) and dry place, protected from light.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
2 mg+500 mg
Synovia Pharma PLC.
৳ ১৭.৬৪ ৳ ১৮.০০ ২% ছাড় প্রতি ইউনিট
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।